about
A critical role for OX40 in T cell-mediated immunopathology during lung viral infectionIRF5 promotes inflammatory macrophage polarization and TH1-TH17 responsesBacterial complications during pandemic influenza infection.An absence of reactive oxygen species improves the resolution of lung influenza infection.Respiratory infections: do we ever recover?Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.Epidemiological isolation causing variable mortality in Island populations during the 1918-1920 influenza pandemic.A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammationFunctional group/guild modelling of inter-specific pathogen interactions: a potential tool for predicting the consequences of co-infection.The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung.Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infectionEvidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRRFlow cytometric measurement of intracellular cytokines.The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine.Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action.Chronic bacterial infections: living with unwanted guests.Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent mannerRole of CCL5 (RANTES) in viral lung disease.Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfectionOX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.Co-stimulation: novel methods for preventing viral-induced lung inflammation.Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lungParenteral fluids do not affect pulmonary immune responses to influenza or susceptibility to secondary bacterial pneumonia in mice.Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology.Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathologyEliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.The therapeutic potential of positive and negative immune cell co-stimulation during inflammation.Manipulation of acute inflammatory lung disease.Immune homeostasis in the respiratory tract and its impact on heterologous infection.Sedation & immunomodulation.The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia.OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection.Airway immune homeostasis and implications for influenza-induced inflammation.The microbiology of asthma.Respiratory viral infections: knowledge based therapeutics.
P50
Q24672415-06A30C69-CD8D-4CC9-BC74-96DADFDF0E1DQ28303437-D002B1F4-4A1F-4A10-A5D1-76EFAECBE29FQ30228111-9F3349EA-0C7D-4F6A-9420-277C77A1B776Q30354387-7DD045FF-EF5B-4C92-A6E0-5A103E98A1C7Q30366426-5F1A5898-2EC7-4FF6-8061-D2C396316F3EQ30366662-7C48F0AA-873A-4AAD-97BC-146B8991BBDEQ30367425-15308034-FB03-45D4-90CF-E7684323E4FCQ30411434-6404569D-7E48-4EC1-8CB9-A2F1B3E553D7Q30432740-AED29CB3-EB98-48CD-A211-6A57850320B7Q33334278-CBDAE476-2AF8-436D-A18B-0585781CBE5BQ33535780-DD6379C6-CDF3-4256-B6E6-7456F167B534Q33781375-4E32D69F-C3D6-4361-A4F7-A19EB72A563FQ33884220-F2644391-A10D-4D70-927A-5D12FA90C276Q34032203-DAF3F3AA-9578-40D9-9F9F-8570E12DA18BQ34164122-F4C7C117-6957-4FBD-929C-72DCCD54CFA1Q34492614-F2ED08E6-D781-4885-B60C-EC9F6CB89CB8Q34647519-47835127-7B6A-48A1-B711-1736A5A54E97Q34718771-913E8BE4-1B12-40A2-B076-55D5494840B6Q34983834-B2E19640-B034-4978-B889-4A6B7091B552Q35011426-569A6D0E-63BD-485A-A555-00D81AE7BF32Q35024052-C620F106-1E21-4502-8841-502F3EF92A71Q35188455-4FFDC546-F6AF-4210-91F4-23D230949A99Q35766002-AE79FEA4-7E75-4BEA-B129-15A46B1324FEQ35862706-E7850E58-5F1E-4867-991D-05C2D444D6CCQ36064557-D0671454-58A7-49F9-A68D-48D9C34AA75CQ36187032-8DDB0733-3F1B-49DA-A283-67DE4FF6AE7FQ36251498-0CBA7A08-A624-4EB3-A244-A9878EB42526Q36369076-00FC7EEE-D49D-4051-848E-57F43F8D2390Q36369101-AEDA27C3-665F-442B-99A4-9376DC25359FQ36400958-2B98934C-98C5-4520-B39E-C1DFB8001141Q36638912-1A3507F3-3FBD-4D4A-B610-32AA27D880CCQ37349724-12546146-8279-4F92-A4B9-7DA781A2B0AAQ37395180-7AC30E3B-4FF3-4032-9A30-3D881B9EBD12Q37540724-7F214058-ED84-422F-9A2B-5AB5A076F8D6Q37554600-2EE6ED7D-7D77-47DC-A11A-D03DAA4E6E8EQ37587734-5BBE7E01-B109-4EB8-8FEA-5A6AF3DFB878Q37860486-5F8D25E6-F520-4FAB-A87C-0C6CABC908DDQ37879771-FE57A050-F28A-4CA0-A706-83011B32722FQ38016314-EDEF0EE8-4993-4C06-B0B2-C0B86578A272Q38024439-5942BAE9-0EE1-497C-A2A9-6E0AD9EF910A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tracy Hussell
@ast
Tracy Hussell
@en
Tracy Hussell
@es
Tracy Hussell
@nl
Tracy Hussell
@sl
type
label
Tracy Hussell
@ast
Tracy Hussell
@en
Tracy Hussell
@es
Tracy Hussell
@nl
Tracy Hussell
@sl
prefLabel
Tracy Hussell
@ast
Tracy Hussell
@en
Tracy Hussell
@es
Tracy Hussell
@nl
Tracy Hussell
@sl
P1053
O-4630-2014
P106
P1153
7004205629
P1960
hpbSnj4AAAAJ
P21
P31
P3829
P4789
P496
0000-0001-7186-6141
P569
1967-04-14T00:00:00Z